4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:June 23, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:June 23, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:June 23, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
8-K: Report of unscheduled material events or corporate event Post author:andrewkaretas Post published:June 23, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading8-K: Report of unscheduled material events or corporate event
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:June 12, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing Post author:andrewkaretas Post published:June 10, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing
10-Q: Quarterly report which provides a continuing view of a company’s financial position Post author:andrewkaretas Post published:May 13, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading10-Q: Quarterly report which provides a continuing view of a company’s financial position
8-K: Report of unscheduled material events or corporate event Post author:andrewkaretas Post published:May 13, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading8-K: Report of unscheduled material events or corporate event
SCHEDULE 13G: SCHEDULE 13G – Description Post author:andrewkaretas Post published:May 13, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingSCHEDULE 13G: SCHEDULE 13G – Description
SCHEDULE 13G/A: SCHEDULE 13G/A – Description Post author:andrewkaretas Post published:May 9, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingSCHEDULE 13G/A: SCHEDULE 13G/A – Description
